SlideShare a Scribd company logo
GOUT
(Pharmacology and therapeutics)
Pawan maharjan
Introduction
• Gout is disorder of purine metabolism in which the blood
uric acid level is raised either due to over production or
impaired excretion.
• Normal plasma uric acid 3.4–7.2 mg/dl for men and for
female 2.4–6.1 mg/ dl).
• Uric acid, a product of purine metabolism, has low water
solubility, especially at low pH.
• When blood uric acid levels are high, it precipitates and
deposits in joints, kidney and subcutaneous tissue as
sodium urate, which causes pain and inflammation of such
parts.
• If not treated, it might cause permanent deformities of
joint aswell.
Etiology
• Hyperuricaemia
• Reason for hyperuricemia
– Consumption of high purine diet
– Impaired in excretion due to kidney disease
– Degradation of muscle
– Drug induced: Frusemide, levodopa, thiazide
– Obesity
TYPES OF GOUT
• Primary gout: It is usually due overproduction or under
excretion without any other secondary cause or disease
condition.
• Secondary gout: It occur due secondary disease or due to
use of medicines
a) Leukaemias, lymphomas, polycythaemia especially
when treated with chemotherapy or radiation: due to
enhanced nucleic acid metabolism and uric acid
production.
(b) Drug induced-thiazides, furosemide, pyrazinamide,
ethambutol, levodopa, reduce uric acid excretion by kidney
Types of gout according to onset
Acute Gout: Chronic Gout
Chronic gout
In chronic case tophi
(chalk-like Stones under
the skin in pinna, eyelids,
nose, joints and other
places) and urate stone in
kidney.
Chronic gouty arthritis
may cause progressive
disability and permanent
deformities.
Pathogenesis of Gout
Clinical features
Swollen and Inflammation of joint,
mainly monoarticular.
Intense pain and tender in joint
• Primarily affect metatarso
phalangeal joint of big toe
• Limited range of movement
• Crystal deposit on pinna, elbow,
knees
• Formation of Tophy
• Gouty nephrolithiasis/nephropathy
Non pharmacological
• Avoid Purine containing food: Red meat, beer
• Avoid Junk food.
• Daily exercise
• Weight management
• Stress management
Pharmacological managment
Classification of medicines
1) Acute attack of gout:
– NSAIDs
– Colchicine
– Corticosteroids
2) For chronic gout and long term control.
– Uricosurics: Probenecid, Sulfinpyrazone
– Synthesis inhibitor: Allopurinol, Febuxostat
Medicine for acute attack
NSAID: Indomethacin, Diclofenac, naproxen, aceclofenac etc.
• But Aspirin is not used as it might decrease excretion of uric acid
Corticosteroid: Prednisolone, methylprednisolone,
• They are used due to strong anti-inflammatory and analgesic property.
• They are not recommended for long term use due to toxicity
Colchine: Dose: 0.25-1 mg
• It is an alkaloid derived from Colchicum autumnale.
• Colchicine does not have analgesic nor anti inflammatory as NSAID but
it specifically suppresses gouty inflammation.
• Chronic therapy might cause: aplastic anemia, agranulocytosis, hair
loss , myopathy, oligospermia, Azospermia
• Other: G.I irritation
•
Medicine for chronic use
Uricosuric agent:
• Probencid, Sulfinpyrazone
• These are the medicine which decrease the
uric acid by increasing its excretion.
• Dose of probencid: Dose: 0.25 gm- 0.5 gm
twice daily.
Uricosuric agent
• Adverse effects of probencid :
• Probenecid is generally well tolerated.
• Dyspepsia/indigestion t (up to 25% incidence with high
doses).
• It should be used cautiously in peptic ulcer patients.
• Rashes and other hypersensitivity phenomena are rare.
• Toxic doses cause convulsions and respiratory failure
Uricosuric agent
• Sulfinpyrazone.
• Pharmacological action is similar to probencid
• Pharmacokinetics:
• It is well absorbed orally and 98% plasma protein
bound.
• Excretion is fairly rapid, mainly by active secretion in
proximal tubule
• Dose: 100-200mg od/bd
• Adverse effects : Gastric irritation is most common so
contraindicated in peptic ulcer.
• Rarely: hypersensitivity reaction.
Uric acid synthesis inhibitors; Allopurinol
and febuxostat
These drug inhibit synthesis of uric acid.
Allopurinol:
Dose: Start with 100 mg OD,
gradually increase to maintenance
dose of 300 mg/day; maximum 600
mg/day
Adr: N/V, skin rashes
Febuxostat:
Dose: 40 mg/d - 80 mg/d; maximum
120 mg/d
Adverse effect:
Liver damage
Hypersensitivity reaction
Diarrhoea, nausea, headache
,Diet
Thank you

More Related Content

Similar to Gout pharmacotherapeutics.pptx

Drugs used in gout
Drugs used in goutDrugs used in gout
Drugs used in gout
AsgharullahKhan
 
Pharmacotherapy of Gout.pptx
Pharmacotherapy of Gout.pptxPharmacotherapy of Gout.pptx
Pharmacotherapy of Gout.pptx
Dr.Arun Marshalin
 
Gout treatment Strategy/ Antigout drugs Lec-1.pptx
Gout treatment Strategy/ Antigout drugs Lec-1.pptxGout treatment Strategy/ Antigout drugs Lec-1.pptx
Gout treatment Strategy/ Antigout drugs Lec-1.pptx
AqsaMushtaq32
 
Pathophysiology and clinical management of gouty arthritis
Pathophysiology and clinical management of gouty arthritisPathophysiology and clinical management of gouty arthritis
Pathophysiology and clinical management of gouty arthritis
Soujanya Pharm.D
 
Pharmacology of gout
Pharmacology of goutPharmacology of gout
Pharmacology of gout
Muhammad_hamza
 
GOUT 3rd Pharm D Pharmacotherapeutics.pptx
GOUT 3rd Pharm D Pharmacotherapeutics.pptxGOUT 3rd Pharm D Pharmacotherapeutics.pptx
GOUT 3rd Pharm D Pharmacotherapeutics.pptx
JSSravaniVedantam
 
ANTI GOUT DRUGS.....pptx
ANTI GOUT DRUGS.....pptxANTI GOUT DRUGS.....pptx
ANTI GOUT DRUGS.....pptx
RupaSingh83
 
gout and anti gout drugs pharmacology
gout and anti gout drugs pharmacologygout and anti gout drugs pharmacology
gout and anti gout drugs pharmacology
Koppala RVS Chaitanya
 
HYPERURICAEMIA + all related brand training material.pptx
HYPERURICAEMIA  + all related brand training material.pptxHYPERURICAEMIA  + all related brand training material.pptx
HYPERURICAEMIA + all related brand training material.pptx
Pabitra Thapa
 
Gout(inflammatory joint disease)
Gout(inflammatory joint disease)Gout(inflammatory joint disease)
Gout(inflammatory joint disease)
Health Forager
 
Gout
GoutGout
Rheumatoid arthritis and gout.ppt
Rheumatoid arthritis and gout.pptRheumatoid arthritis and gout.ppt
Rheumatoid arthritis and gout.ppt
Abhinav kanwal
 
Gouty arthritis
Gouty arthritisGouty arthritis
Gouty arthritis
Nirav Prajapati
 
Gout and RA Drugs
Gout and RA DrugsGout and RA Drugs
Gout and RA Drugs
sarosem
 
GOUTY ARTHRITIS
GOUTY ARTHRITISGOUTY ARTHRITIS
GOUTY ARTHRITIS
Samuel Nimoh
 
Gout
GoutGout
Gout (1)
Gout (1)Gout (1)
Gout (1)
madhavsiree
 
Uric acid disorders
Uric acid disordersUric acid disorders
Uric acid disorders
Dr. Lalit Agarwal
 
Gout arthritis - comprehensive ppt
Gout arthritis - comprehensive pptGout arthritis - comprehensive ppt
Gout arthritis - comprehensive ppt
RAJASEKHAR YALAMANCHI
 
Anti gout drugs.pdf
Anti gout drugs.pdfAnti gout drugs.pdf
Anti gout drugs.pdf
Koppala RVS Chaitanya
 

Similar to Gout pharmacotherapeutics.pptx (20)

Drugs used in gout
Drugs used in goutDrugs used in gout
Drugs used in gout
 
Pharmacotherapy of Gout.pptx
Pharmacotherapy of Gout.pptxPharmacotherapy of Gout.pptx
Pharmacotherapy of Gout.pptx
 
Gout treatment Strategy/ Antigout drugs Lec-1.pptx
Gout treatment Strategy/ Antigout drugs Lec-1.pptxGout treatment Strategy/ Antigout drugs Lec-1.pptx
Gout treatment Strategy/ Antigout drugs Lec-1.pptx
 
Pathophysiology and clinical management of gouty arthritis
Pathophysiology and clinical management of gouty arthritisPathophysiology and clinical management of gouty arthritis
Pathophysiology and clinical management of gouty arthritis
 
Pharmacology of gout
Pharmacology of goutPharmacology of gout
Pharmacology of gout
 
GOUT 3rd Pharm D Pharmacotherapeutics.pptx
GOUT 3rd Pharm D Pharmacotherapeutics.pptxGOUT 3rd Pharm D Pharmacotherapeutics.pptx
GOUT 3rd Pharm D Pharmacotherapeutics.pptx
 
ANTI GOUT DRUGS.....pptx
ANTI GOUT DRUGS.....pptxANTI GOUT DRUGS.....pptx
ANTI GOUT DRUGS.....pptx
 
gout and anti gout drugs pharmacology
gout and anti gout drugs pharmacologygout and anti gout drugs pharmacology
gout and anti gout drugs pharmacology
 
HYPERURICAEMIA + all related brand training material.pptx
HYPERURICAEMIA  + all related brand training material.pptxHYPERURICAEMIA  + all related brand training material.pptx
HYPERURICAEMIA + all related brand training material.pptx
 
Gout(inflammatory joint disease)
Gout(inflammatory joint disease)Gout(inflammatory joint disease)
Gout(inflammatory joint disease)
 
Gout
GoutGout
Gout
 
Rheumatoid arthritis and gout.ppt
Rheumatoid arthritis and gout.pptRheumatoid arthritis and gout.ppt
Rheumatoid arthritis and gout.ppt
 
Gouty arthritis
Gouty arthritisGouty arthritis
Gouty arthritis
 
Gout and RA Drugs
Gout and RA DrugsGout and RA Drugs
Gout and RA Drugs
 
GOUTY ARTHRITIS
GOUTY ARTHRITISGOUTY ARTHRITIS
GOUTY ARTHRITIS
 
Gout
GoutGout
Gout
 
Gout (1)
Gout (1)Gout (1)
Gout (1)
 
Uric acid disorders
Uric acid disordersUric acid disorders
Uric acid disorders
 
Gout arthritis - comprehensive ppt
Gout arthritis - comprehensive pptGout arthritis - comprehensive ppt
Gout arthritis - comprehensive ppt
 
Anti gout drugs.pdf
Anti gout drugs.pdfAnti gout drugs.pdf
Anti gout drugs.pdf
 

More from Pawan Maharjan

DIC workshop for staff nurse students.pptx
DIC workshop for staff nurse students.pptxDIC workshop for staff nurse students.pptx
DIC workshop for staff nurse students.pptx
Pawan Maharjan
 
peptic ulcer pharmcological managment.pptx
peptic ulcer pharmcological managment.pptxpeptic ulcer pharmcological managment.pptx
peptic ulcer pharmcological managment.pptx
Pawan Maharjan
 
pharmcotherapeutic RHEUMATOID ARTHRITIS.pptx
pharmcotherapeutic RHEUMATOID ARTHRITIS.pptxpharmcotherapeutic RHEUMATOID ARTHRITIS.pptx
pharmcotherapeutic RHEUMATOID ARTHRITIS.pptx
Pawan Maharjan
 
drug use in treatment rheumatoid arthritis
drug use in treatment  rheumatoid arthritisdrug use in treatment  rheumatoid arthritis
drug use in treatment rheumatoid arthritis
Pawan Maharjan
 
antigonadal hormones detail pharmacology.
antigonadal hormones detail pharmacology.antigonadal hormones detail pharmacology.
antigonadal hormones detail pharmacology.
Pawan Maharjan
 
psychosis.pptx
psychosis.pptxpsychosis.pptx
psychosis.pptx
Pawan Maharjan
 
alcoholic liver diseases.pptx
alcoholic liver diseases.pptxalcoholic liver diseases.pptx
alcoholic liver diseases.pptx
Pawan Maharjan
 
brucellosis.pptx
brucellosis.pptxbrucellosis.pptx
brucellosis.pptx
Pawan Maharjan
 
rhinitis.pptx
rhinitis.pptxrhinitis.pptx
rhinitis.pptx
Pawan Maharjan
 
community pharamcy.pptx
community pharamcy.pptxcommunity pharamcy.pptx
community pharamcy.pptx
Pawan Maharjan
 
enterpreneurship.pptx
enterpreneurship.pptxenterpreneurship.pptx
enterpreneurship.pptx
Pawan Maharjan
 
Therapeutic Drug Monitoring.pptx
Therapeutic Drug Monitoring.pptxTherapeutic Drug Monitoring.pptx
Therapeutic Drug Monitoring.pptx
Pawan Maharjan
 
other hormones.pptx
other hormones.pptxother hormones.pptx
other hormones.pptx
Pawan Maharjan
 
digoxin.pdf
digoxin.pdfdigoxin.pdf
digoxin.pdf
Pawan Maharjan
 

More from Pawan Maharjan (14)

DIC workshop for staff nurse students.pptx
DIC workshop for staff nurse students.pptxDIC workshop for staff nurse students.pptx
DIC workshop for staff nurse students.pptx
 
peptic ulcer pharmcological managment.pptx
peptic ulcer pharmcological managment.pptxpeptic ulcer pharmcological managment.pptx
peptic ulcer pharmcological managment.pptx
 
pharmcotherapeutic RHEUMATOID ARTHRITIS.pptx
pharmcotherapeutic RHEUMATOID ARTHRITIS.pptxpharmcotherapeutic RHEUMATOID ARTHRITIS.pptx
pharmcotherapeutic RHEUMATOID ARTHRITIS.pptx
 
drug use in treatment rheumatoid arthritis
drug use in treatment  rheumatoid arthritisdrug use in treatment  rheumatoid arthritis
drug use in treatment rheumatoid arthritis
 
antigonadal hormones detail pharmacology.
antigonadal hormones detail pharmacology.antigonadal hormones detail pharmacology.
antigonadal hormones detail pharmacology.
 
psychosis.pptx
psychosis.pptxpsychosis.pptx
psychosis.pptx
 
alcoholic liver diseases.pptx
alcoholic liver diseases.pptxalcoholic liver diseases.pptx
alcoholic liver diseases.pptx
 
brucellosis.pptx
brucellosis.pptxbrucellosis.pptx
brucellosis.pptx
 
rhinitis.pptx
rhinitis.pptxrhinitis.pptx
rhinitis.pptx
 
community pharamcy.pptx
community pharamcy.pptxcommunity pharamcy.pptx
community pharamcy.pptx
 
enterpreneurship.pptx
enterpreneurship.pptxenterpreneurship.pptx
enterpreneurship.pptx
 
Therapeutic Drug Monitoring.pptx
Therapeutic Drug Monitoring.pptxTherapeutic Drug Monitoring.pptx
Therapeutic Drug Monitoring.pptx
 
other hormones.pptx
other hormones.pptxother hormones.pptx
other hormones.pptx
 
digoxin.pdf
digoxin.pdfdigoxin.pdf
digoxin.pdf
 

Recently uploaded

Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
sisternakatoto
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
aljamhori teaching hospital
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
DR SETH JOTHAM
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
DrSathishMS1
 

Recently uploaded (20)

Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,263778731218 Abortion Clinic /Pills In Harare ,
263778731218 Abortion Clinic /Pills In Harare ,
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
basicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdfbasicmodesofventilation2022-220313203758.pdf
basicmodesofventilation2022-220313203758.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIONDACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
ACUTE SCROTUM.....pdf. ACUTE SCROTAL CONDITIOND
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all24 Upakrama.pptx class ppt useful in all
24 Upakrama.pptx class ppt useful in all
 

Gout pharmacotherapeutics.pptx

  • 2. Introduction • Gout is disorder of purine metabolism in which the blood uric acid level is raised either due to over production or impaired excretion. • Normal plasma uric acid 3.4–7.2 mg/dl for men and for female 2.4–6.1 mg/ dl). • Uric acid, a product of purine metabolism, has low water solubility, especially at low pH. • When blood uric acid levels are high, it precipitates and deposits in joints, kidney and subcutaneous tissue as sodium urate, which causes pain and inflammation of such parts. • If not treated, it might cause permanent deformities of joint aswell.
  • 3. Etiology • Hyperuricaemia • Reason for hyperuricemia – Consumption of high purine diet – Impaired in excretion due to kidney disease – Degradation of muscle – Drug induced: Frusemide, levodopa, thiazide – Obesity
  • 4. TYPES OF GOUT • Primary gout: It is usually due overproduction or under excretion without any other secondary cause or disease condition. • Secondary gout: It occur due secondary disease or due to use of medicines a) Leukaemias, lymphomas, polycythaemia especially when treated with chemotherapy or radiation: due to enhanced nucleic acid metabolism and uric acid production. (b) Drug induced-thiazides, furosemide, pyrazinamide, ethambutol, levodopa, reduce uric acid excretion by kidney
  • 5. Types of gout according to onset Acute Gout: Chronic Gout
  • 6. Chronic gout In chronic case tophi (chalk-like Stones under the skin in pinna, eyelids, nose, joints and other places) and urate stone in kidney. Chronic gouty arthritis may cause progressive disability and permanent deformities.
  • 8.
  • 9. Clinical features Swollen and Inflammation of joint, mainly monoarticular. Intense pain and tender in joint • Primarily affect metatarso phalangeal joint of big toe • Limited range of movement • Crystal deposit on pinna, elbow, knees • Formation of Tophy • Gouty nephrolithiasis/nephropathy
  • 10. Non pharmacological • Avoid Purine containing food: Red meat, beer • Avoid Junk food. • Daily exercise • Weight management • Stress management
  • 11. Pharmacological managment Classification of medicines 1) Acute attack of gout: – NSAIDs – Colchicine – Corticosteroids 2) For chronic gout and long term control. – Uricosurics: Probenecid, Sulfinpyrazone – Synthesis inhibitor: Allopurinol, Febuxostat
  • 12. Medicine for acute attack NSAID: Indomethacin, Diclofenac, naproxen, aceclofenac etc. • But Aspirin is not used as it might decrease excretion of uric acid Corticosteroid: Prednisolone, methylprednisolone, • They are used due to strong anti-inflammatory and analgesic property. • They are not recommended for long term use due to toxicity Colchine: Dose: 0.25-1 mg • It is an alkaloid derived from Colchicum autumnale. • Colchicine does not have analgesic nor anti inflammatory as NSAID but it specifically suppresses gouty inflammation. • Chronic therapy might cause: aplastic anemia, agranulocytosis, hair loss , myopathy, oligospermia, Azospermia • Other: G.I irritation •
  • 13. Medicine for chronic use Uricosuric agent: • Probencid, Sulfinpyrazone • These are the medicine which decrease the uric acid by increasing its excretion. • Dose of probencid: Dose: 0.25 gm- 0.5 gm twice daily.
  • 14. Uricosuric agent • Adverse effects of probencid : • Probenecid is generally well tolerated. • Dyspepsia/indigestion t (up to 25% incidence with high doses). • It should be used cautiously in peptic ulcer patients. • Rashes and other hypersensitivity phenomena are rare. • Toxic doses cause convulsions and respiratory failure
  • 15. Uricosuric agent • Sulfinpyrazone. • Pharmacological action is similar to probencid • Pharmacokinetics: • It is well absorbed orally and 98% plasma protein bound. • Excretion is fairly rapid, mainly by active secretion in proximal tubule • Dose: 100-200mg od/bd • Adverse effects : Gastric irritation is most common so contraindicated in peptic ulcer. • Rarely: hypersensitivity reaction.
  • 16. Uric acid synthesis inhibitors; Allopurinol and febuxostat These drug inhibit synthesis of uric acid. Allopurinol: Dose: Start with 100 mg OD, gradually increase to maintenance dose of 300 mg/day; maximum 600 mg/day Adr: N/V, skin rashes Febuxostat: Dose: 40 mg/d - 80 mg/d; maximum 120 mg/d Adverse effect: Liver damage Hypersensitivity reaction Diarrhoea, nausea, headache ,Diet